Correlation Between Pmv Pharmaceuticals and Immunome
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Immunome, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Immunome.
Diversification Opportunities for Pmv Pharmaceuticals and Immunome
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pmv and Immunome is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Immunome go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Immunome
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.54 times more return on investment than Immunome. However, Pmv Pharmaceuticals is 1.84 times less risky than Immunome. It trades about -0.07 of its potential returns per unit of risk. Immunome is currently generating about -0.12 per unit of risk. If you would invest 160.00 in Pmv Pharmaceuticals on November 27, 2024 and sell it today you would lose (17.00) from holding Pmv Pharmaceuticals or give up 10.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Immunome
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Immunome |
Pmv Pharmaceuticals and Immunome Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Immunome
The main advantage of trading using opposite Pmv Pharmaceuticals and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |